Blockchain Registration Transaction Record

SS Innovations Hits Record Q2 Revenue of $13.9M, Up 39.4%

SS Innovations reports record Q2 2026 revenue of $13.9M, up 39.4%, with SSi Mantra installations rising 30.4%. Telesurgery milestone achieved. FDA decision expected by Q1 2027.

This news is significant because SS Innovations is rapidly expanding its footprint in the surgical robotics market, with record revenue and installations underscoring growing adoption of its SSi Mantra system. The completion of a transcontinental telesurgery demonstrates the potential to bring expert surgical care to remote areas, potentially transforming healthcare access globally. With regulatory approvals pending in the U.S. and Europe, the company is on the cusp of entering major markets, which could intensify competition and drive down costs in robotic surgery, ultimately benefiting patients and healthcare systems worldwide.